PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) announced that its management team will participate in two upcoming investor conferences in February and March, where executives will deliver ...
Translate Bio, Inc. is an early-clinical-stage biotechnology company developing mRNA therapeutics and vaccines targeting protein or gene dysfunction and infectious diseases respectively. Translate Bio ...
Bio Equity Risk Management has formed as a Boston-based investment firm focused on special situations opportunities in the healthcare industry. The firm’s co-founding managing partners are Nessan ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T ...
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side analysts ...
Propel Bio Partners is a leading global venture fund specializing in life science investments, offering a comprehensive ecosystem of experts to empower entrepreneurs to realize their visions. Richard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results